When is FTO Frauen actually useful?

The utility of FTO (Fat Mass and Obesity Associated) gene testing in women is limited and evidence-dependent. Most associations, such as those between the rs9939609 variant and increased BMI, appetite, or reduced satiety, come from GWAS with small effect sizes (e.g., ~0.3 kg/m² BMI increase per risk allele). There is no strong evidence that FTO status alone should guide clinical decisions for women. In specific scenarios like obesity surgery planning or PCOS management, knowing FTO genotype might theoretically inform risk awareness, but no robust intervention studies show benefit. MyBody-X may include FTO markers in its DNA tests, but these are intended for lifestyle insight, not medical diagnosis. For women considering pregnancy or during pregnancy, no guidelines recommend FTO testing. The main value is educational: understanding one's genetic predisposition can motivate lifestyle changes, but it should not replace standard care. Evidence grade: GWAS/observational. Caveat: small effect, ancestry-dependent, and no proven clinical utility for individual women. Always consult a healthcare provider before making health decisions based on genetic results.